{"title":"Prevalence, Pathogenesis and Identification of Clinical Risk Factors Associated with Dengue Virus (DENV)","authors":"Mohsina F.P, Faheem I.P, M. Mukim, Shahana Tabassum, Shoheb Tarkash, I. Shah, Abhinandan H. Patil","doi":"10.35652/igjps.2022.12023","DOIUrl":null,"url":null,"abstract":"Dengue, also called the break bone fever. Dengue disease is caused by dengue virus (DENV) having four categories that escalate by the bite of infected Aedes mosquito’s family are Flaviviridae. The infected person shows the signs and symptoms from mild asymptomatic changes with fever to severe deadly dengue hemorrhagicfever/dengue shock syndrome (DHF/DSS). Nearly 2.5-3 billion people stay in dengue-prone areas with more than 100 million new cases ruled out every year worldwide. Number of Dengue cases has increased tremendous ratio in recent years with sudden risk of the increase in the size of human population. A condition known as viremia (medical term: virus present in blood) occurs due to spread of DENV, which represents high level of viruses in bloodstream of patient. In response the immune system gets activated and produces antibodies against the dengue viral particles, which in turn activates the complement cascade which in combination of the antibodies and WBC get rid of the virus. The cytotoxic T cells (CD8+ T) produced by the body immune system, which identifies and destroy infected cells. Dengue spreads drastically, its virus regress the immunity of body. DENV reduces the bodies’ resistance and decreases the Platelets count and Hemoglobin. Fall in blood pressure and bleeding from Nose and Gums, Dehydration can occur. Small blood vessels are fragile, the fluid in the body leaks out, accumulate in the lungs. When there is bleeding, the fluid is accumulated in the stomach it can result to mortality or can be fatal. The DENV-3 infection cause Dengue Viral Hemorrhagicfever (VHFs)which is severe and fatal form of the disease. The main Dengue shock syndrome is the most severe form of Dengue Hemorrhagicfever. Dengue has presently become a complex issue according to pathophysiological, economic and ecologic. In the last 5 decades anumber of treatment strategies and plans to control dengue came out in India, but the scientific studies related to various problems of dengue disease have been a limited resource in the centerswhere treatment was carried out. The key note point to reduce the number of disease related morbidity and mortality has to be carried out by early identification and immediate commencement of proper treatment.©2022iGlobal Research and PublishingFoundation. All rights reserved.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indo Global Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35652/igjps.2022.12023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
登革病毒(DENV)的流行、发病机制及临床危险因素鉴定
登革热,也叫断骨热。登革热是由登革热病毒(DENV)引起的疾病,该病毒有四种类型,通过受感染的伊蚊叮咬而升级,其科为黄病毒科。感染者表现出从轻度无症状发热到严重致命登革出血热/登革休克综合征(DHF/DSS)的体征和症状。近25亿至30亿人生活在登革热易发地区,全世界每年排除1亿多新病例。近年来登革热病例数以惊人的速度增长,伴随着人口规模的突然增加。病毒血症(医学术语:存在于血液中的病毒)是由于DENV的传播而发生的,它代表患者血液中的病毒水平很高。作为回应,免疫系统被激活并产生针对登革热病毒颗粒的抗体,这反过来又激活补体级联,抗体和白细胞结合,消除病毒。由身体免疫系统产生的细胞毒性T细胞(CD8+ T),它能识别并摧毁被感染的细胞。登革热传播迅速,其病毒削弱了机体的免疫力。DENV降低了身体的抵抗力,降低了血小板计数和血红蛋白。血压下降,鼻子和牙龈出血,可能发生脱水。小血管很脆弱,体内的液体漏出,积聚在肺部。当出现出血时,胃液会积聚在胃中,这可能导致死亡或致命。DENV-3感染引起登革病毒出血热(VHFs),这是该疾病的严重和致命形式。主要的登革休克综合征是登革出血热最严重的形式。登革热目前已成为一个复杂的病理生理、经济和生态问题。在过去的50年里,印度出现了许多控制登革热的治疗策略和计划,但与登革热各种问题相关的科学研究在进行治疗的中心一直是有限的资源。减少与疾病有关的发病率和死亡率的关键要点必须通过早期发现和立即开始适当治疗来实现。©2022全球研究与出版基金会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。